SenesTech, Inc. (SNES): Nasdaq/NYSE listing notice — SenesTech receives extended deadline to Aug 19, 2024 for Nasdaq bid price compliance

SenesTech, Inc.

Failed to regain minimum $1.00 bid price by Feb 21, 2024; Nasdaq grants second 180-day period.
Must have closing bid ≥ $1.00 for at least 10 consecutive business days during the new period.
If not compliant by August 19, 2024, Staff will notify of delisting; company may appeal.
Eligibility for extension required meeting other Nasdaq Capital Market listing standards.
Company intends to cure deficiency through a reverse stock split if needed.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SenesTech, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 26, 2024, we received notice from Nasdaq indicating that, while we have not regained compliance with the Rule, the Staff has determined that we are eligible for an additional 180 calendar day period, or until August 19, 2024, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and (ii) our providing written notice to Nasdaq of our intent to cure the de

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SenesTech, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-007200

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.